FDA Adverse Event Malfunction Summary report: N

ECHELON*FLEX60 ARTICULATING

MDR report key: 3931573 · Received July 14, 2014

Report

Report Number
3005075853-2014-04902
Event Type
Malfunction
Date Received
July 14, 2014
Date of Event
June 2, 2014
Report Date
June 4, 2014
Manufacturer
ETHICON ENDO-SURGERY, LLC.
Product Code
GDW
PMA / PMN Number
K081146
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(6) - DAMAGED CARTRIDGE, DAMAGED ONE PIECE SLED, DAMAGED DRIVERS. THE ANALYSIS FOUND THAT ONE EC60A DEVICE WAS RETURNED IN GOOD VISUAL CONDITION AND WITH AN ECR60D CARTRIDGE LOADED ON THE DEVICE. THE RELOAD WAS RECEIVED PARTIALLY FIRED 1/4. UPON EVALUATION OF THE RELOAD, THE CARTRIDGE BODY, ONE PIECE SLED AND SOME DRIVERS WERE NOTED TO BE DAMAGED. NO OBVIOUS DAMAGE TO THE CARTRIDGE DECK WAS NOTED, WHICH SUGGESTS THE CARTRIDGE, MAY NOT HAVE BEEN FIRED OVER A HARD OBJECT. AS ADDITIONAL TESTING, THE DEVICE WAS TESTED FOR FUNCTIONALITY IN THE ARTICULATED POSITION WITH A TEST CARTRIDGE RELOAD AND ACHIEVED ITS COMPLETE FIRING SEQUENCE WITHOUT ANY DIFFICULTIES. THE STAPLE LINE AND CUT LINE WERE COMPLETE AND THE STAPLES WERE NOTED TO HAVE THE PROPER B-FORM SHAPE. THE BATCH RECORD WAS REVIEWED AND NO ANOMALIES WERE NOTED DURING THE MANUFACTURING PROCESS.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A LAPAROSCOPIC LOW ANTERIOR RESECTION PROCEDURE, THE FIRING TRIGGER COULD NOT BE FULLY GRASPED AT THE 1ST STROKE OF THE 2ND FIRING WHEN THE DEVICE WAS USED ON THE RECTUM. THE CARTRIDGE WAS GOLD. REINFORCEMENT MATERIAL WAS NOT USED. ANOTHER DEVICE WAS USED TO COMPLETE THE CASE. THERE WERE NO ADVERSE CONSEQUENCES TO THE PATIENT. WHEN THE SALES REP RECEIVED THE DEVICE, THE CARTRIDGE WAS DAMAGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
409430 ECHELON*FLEX60 ARTICULATING STAPLE, IMPLANTABLE GDW ETHICON ENDO-SURGERY, LLC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 ERC60D